Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 28 Sep 2012
At a glance
- Drugs Paclitaxel (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 03 Jul 2008 New trial record.
- 03 Jun 2008 Celgene Corporation as company and lead trial centre added as reported by ClinicalTrials.gov.